3. In paragraph 1(a) of Schedule 1 (which specifies controlled drugs subject to the requirements of regulations 14, 15, 16 , 18, 19, 20, 23, 26 and 27)—
(a)after “4-Bromo-2,5-dimethoxy-a-methylphenethylamine” insert—
“1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45)”;
(b)after “4-Methyl-aminorex” insert—
“4-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4’-DMAR)”.